{"schema_version":"1","generated_at":"2026-11-05T21:27:50.551Z","data_as_of":null,"url":"https://www.findmykol.com/kol/koji-haratani","json_url":"https://www.findmykol.com/kol/koji-haratani/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"koji-haratani","name":"Koji Haratani","credential":"MDPHD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Harvard University","institution_url":"https://www.findmykol.com/institution/harvard-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1366236408","orcid":"0000-0002-1767-6854","openalex":"A5066972885"},"summary":"Koji Haratani is an Oncology physician affiliated with Harvard University. OpenAlex indexes 100 publications with 4,138 citations (h-index 28).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":100,"cited_by_count":4138,"h_index":28,"latest_activity_year":2025,"source":"works"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Antitumor Activity of Vebreltinib and Characterization of Clinicogenomic Features in Solid Tumors with MET Rearrangements","year":2025,"journal":"Cancer Discovery","source_url":"https://doi.org/10.1158/2159-8290.cd-24-1726","status":"verified"},{"title":"TREX1 Inactivation Unleashes Cancer Cell STING–Interferon Signaling and Promotes Antitumor Immunity","year":2024,"journal":"Cancer Discovery","source_url":"https://doi.org/10.1158/2159-8290.cd-23-0700","status":"verified"},{"title":"Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade","year":2024,"journal":"Journal of Clinical Investigation","source_url":"https://doi.org/10.1172/jci168318","status":"verified"},{"title":"Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer","year":2024,"journal":"British Journal of Cancer","source_url":"https://doi.org/10.1038/s41416-024-02662-2","status":"verified"},{"title":"Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE)","year":2023,"journal":"Journal of Thoracic Oncology","source_url":"https://doi.org/10.1016/j.jtho.2023.06.012","status":"verified"}],"source":"works"},"similar":[{"name":"Thoralf Sundt","slug":"thoralf-sundt","institution":"Harvard University","specialty":"Thoracic Surgery (Cardiothoracic Vascular Surgery)","url":"https://www.findmykol.com/kol/thoralf-sundt","json_url":"https://www.findmykol.com/kol/thoralf-sundt/profile.json"},{"name":"Felipe Fregni","slug":"felipe-fregni","institution":"Harvard University","specialty":"Neurology","url":"https://www.findmykol.com/kol/felipe-fregni","json_url":"https://www.findmykol.com/kol/felipe-fregni/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Sarah Fortune","slug":"sarah-fortune","institution":"Harvard University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/sarah-fortune","json_url":"https://www.findmykol.com/kol/sarah-fortune/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}